Open Text Corporation: Chiron Selects Livelink For Managing FDA Compliance

Business Wire, Jan 23, 2003

Business Editors

CHICAGO--(BUSINESS WIRE)--Jan. 22, 2003

Open Text Further Extends Its Market Leadership in Life Sciences

Open Text(TM) Corporation (Nasdaq:OTEX) (TSX:OTC), provider of Livelink(R), the leading collaboration and knowledge management software for the global enterprise, today announced that Chiron Corporation, a global biopharmaceutical company, has selected Livelink as its enterprise wide solution for managing documents critical to the company's product development, manufacturing, and quality operations.

Following an evaluation of several solutions, Chiron has selected Livelink to replace its existing systems and to provide a single platform for document management. Chiron will be replacing its legacy systems with Livelink, effectively making Livelink its global standard to meet Chiron's regulatory and controlled document needs throughout its locations in North America and Europe.

"Chiron chose Open Text's Livelink solution because of its alignment with our IT architecture strategy," said Meghan Leader, Chiron's Chief Information Officer. "Its Web-based, open architecture and core functionality, as well as its intuitive user interface, were differentiators for us."

In order to achieve new product launches, Chiron must have processes in place to quickly, efficiently and effectively manage the vast numbers of documents currently generated as part of the approval processes for regulatory agencies around the world. Using Livelink, Chiron will be able to manage these paper processes electronically. Livelink also provides online auditing functionality for tracking information, permissions and approvals throughout the product development, regulatory approval and marketing stages.

Chiron will also use Livelink to manage its standard operating procedures (SOPs) for manufacturing processes and quality operations. Maintaining SOPs in a Web-based solution ensures that Chiron employees have access to the same up-to-date, critical information across the enterprise.

"Open Text is committed to fulfilling the complex needs and compliance requirements faced by its customers in regulated industries," said Martin Sumner-Smith, Vice President of Pharmaceutical Solutions, Open Text. "Using Livelink to promote productivity, streamline processes and provide a global standard for managing critical research and development information will enable Chiron to focus on what it does best-product-oriented research, rapid product development, superior manufacturing and commercial strategies for preventing and treating human disease."

About Livelink

Livelink is the leader in collaboration and knowledge management for the global enterprise. Its richly-featured enterprise services include virtual team collaboration, business process automation, enterprise group scheduling and information retrieval services, all tightly integrated into a solution that is easily customized and extended. Livelink is essential to the effective management and development of communities of interest that span organizations and industries. For everything from the creation of complex e-community relationships to the automation of simple e-business processes, Livelink delivers true dynamic collaboration between individuals, organizations and large trading communities. Livelink servers are fully Web-based and open-architected to ensure rapid deployment and easy access to its full functionality through a standard Web browser. For more information, visit www.opentext.com/livelink/

About Chiron

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: vaccines, blood testing, and biopharmaceuticals.

About Open Text

Since 1991, Open Text Corporation has delivered innovative software that brings people together to share knowledge, achieve excellence, deliver innovation, and enhance processes. Its legacy of innovation began with the successful deployment of the world's first search engine technology for the Internet. Today, as the leading global supplier of collaboration and knowledge management software for the enterprise, Open Text supports six million seats across 4,500 corporations in 31 countries and 12 languages throughout the world. As a publicly traded company, Open Text manages and maximizes its resources and relationships to ensure the success of great minds working together. For more information, visit www.opentext.com.

This news release may contain forward-looking statements relating to the deployment of Livelink and Livelink MeetingZone by customers, and future performance of Open Text Corporation. Forward-looking statements are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties include, among others, risks involved in the completion and integration of acquisitions, the possibility of technical, logistical or planning issues in connection with deployments, the continuous commitment of the Company's customers and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission (SEC), including the final prospectus for the Company's initial public offering of common stock in January 1996, Form 10-K for the years ended June 30, of 1996, 1997, 1998, 1999, 2000, 2001, 2002, and Form 10-Q for the quarter ended September 30, 2002. Forward-looking statements are based on management's beliefs and opinions at the time the statements are made, and the Company does not undertake any obligations to update forward-looking statements should circumstances or management's beliefs or opinions change.